Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-24-103453
Filing Date
2024-11-27
Accepted
2024-11-27 16:05:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D ea0222889-13da2mazur_citius.htm SC 13D/A 33765
  Complete submission text file 0001213900-24-103453.txt   35335
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016
Business Address
Mazur Leonard L (Filed by) CIK: 0001463414 (see all company filings)

Type: SC 13D/A

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Subject) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-90253 | Film No.: 241511011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)